Pregestational type 1 (T1DM) and type 2 (T2DM) diabetes mellitus and gestational diabetes
mellitus (GDM) are associated with increased rates of adverse maternal and neonatal …

Glucose concentrations within target, appropriate gestational weight gain, adequate lifestyle,
and, if necessary, antihypertensive treatment and low-dose aspirin reduces the risk of pre …

This is the full version of the Australasian Diabetes in Pregnancy Society (ADIPS) 2020
guideline for pre‐existing diabetes and pregnancy. The guideline encompasses the …

The prevalence of type 2 diabetes (T2DM) at reproductive age is rising. Women with T2DM
have a similarly high risk for pregnancy complications as pregnant women with type 1 …

Aims To examine the relationship between maternal glycaemic control and risk of neonatal
hypoglycaemia using conventional and continuous glucose monitoring metrics in the …

Aims To determine if in‐target intrapartum glucose control is associated with neonatal
hypoglycaemia in women with type 1, type 2 or gestational diabetes. Methods This was a …

Objective Diabetes in pregnancy is a major risk factor for adverse perinatal outcomes such
as congenital anomalies, hypertensive disorders of pregnancy (HDP), and macrosomia. For …

Objective To describe maternal and neonatal glycaemic control following antenatal
corticosteroid administration to women with diabetes in pregnancy. Design Retrospective …

OBJECTIVE: To assess the effect of tight compared with liberalized intrapartum maternal
glucose management on neonatal hypoglycemia risk in pregnancies complicated by …

This article summarises the Joint British Diabetes Societies for Inpatient Care guidelines on
the management of glycaemia in pregnant women with diabetes on obstetric wards and …